LP-284 was found not to be activated by PTGR1 and had strong anti-tumor activity in the 6 hematologic cancer cell lines in the NCI-60 panel (Zhou et al., 2022 Society of Hematologic Oncology conference abstract # MCL319). The gene discussed is PTGR1; the disease is hematopoietic and lymphoid cell neoplasm.